Developing a new neuroscience model is no small feat. New faculty member Brady Weissbourd has risen to the challenge in order to study nervous system evolution, development, regeneration, and function.
Assistant Professor César Terrer and recent visiting student Stephen Bell describe how agricultural lands that are no longer productive could play an important role in carbon sequestration.
New MIT faculty member investigates how sensory input from within the body controls mammalian physiology and behavior.
The CSAIL scientist describes natural language processing research through state-of-the-art machine-learning models and investigation of how language can enhance other types of artificial intelligence.
Urlaub discusses the growing popularity of language programs at the Institute.
CEO Stephanie Khurana describes the nonprofit, whose work is aimed at those without easy access to degree and credential programs.
MIT-Ukraine program leaders describe the work they are undertaking as they shape a novel project to help a country in crisis.
With federal and state public health emergencies expiring on May 11, Cecilia Stuopis and Ian Waitz discuss the next chapter for MIT.
Ali Jadbabaie and Robert van der Hilst discuss how a new joint degree program in climate system science and engineering will prepare students to solve global-scale environmental problems.
MIT’s dean of admissions and student financial services talks about helping rural students better understand their options for going to college.
MIT CSHub Deputy Director Hessam AzariJafari is conducting vital research to investigate the impacts of concrete's carbonation across its life cycle.
MIT scholars discuss the history behind the war, lessons learned on state-building, and Iraq’s current political outlook.
Work of the Future Initiative co-directors Julie Shah and Ben Armstrong describe their vision of “positive-sum automation.”
A new campus series intends to inspire conversation about building community across the Institute.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.